Loading
Latest filing published 01 Aug 2025 for Nuo Therapeutics, Inc., €175k.
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Charles E. Sheedy is a declared insider of Nuo Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 8 filings cover trades dated from 20 June 2016 to 30 July 2025.
The open-market record is one-sided, with 7 purchases worth €2.3M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 1 purchase and no sales.
Half of the purchases are above €114k and half below. On 1 out of 7 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 1 August 2025: an open-market purchase of €175k, in Nuo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations